Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...
The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...
NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...
Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side-effects with long-term use. A recent human trial found that a new drug ...
A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...
Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, ...
Everyday Health on MSN
Understanding 'off' times in advanced Parkinson's disease
Explore off times in advanced Parkinson's disease, understand symptoms, communicate with your doctor, and consider treatment strategies and lifestyle adjustments.
7don MSNOpinion
Two technologies, one disease: Connecting DBS and focused ultrasound for Parkinson's disease management
Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people ...
FRANKLIN, Tenn. (WKRN) – A clinical trial is underway in Middle Tennessee testing whether a pill can help reduce involuntary muscle movements in people with Parkinson’s disease. According to the ...
2don MSN
Scientists report new immune insights and targets into LRRK2 mutations in Parkinson's disease
Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...
News-Medical.Net on MSN
Parkinson’s disease may stem from iron starvation rather than iron overload
This perspective argues that Parkinson’s disease may involve functional iron deficiency, where bioavailable iron is limited despite normal or elevated total iron in the brain. The authors propose that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results